Please login to the form below

Not currently logged in
Email:
Password:

peginterferon beta-1a

This page shows the latest peginterferon beta-1a news and features for those working in and with pharma, biotech and healthcare.

Biogen and AbbVie bag FDA approval for multiple sclerosis drug

Biogen and AbbVie bag FDA approval for multiple sclerosis drug

patients by 45% when compared with Avonex (peginterferon beta-1a) at week 144. ... The new approval adds to Biogen's already sizeable stable of MS drugs on the market, which include Avonex and its long-acting version Plegridy (peginterferon beta-1a), and

Latest news

More from news
Approximately 2 fully matching, plus 6 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Say Communications

Influencing positive behaviours and delivering change is what drives us, using thought leadership, education, social and professional engagement and compelling,...

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics